Search Results - "Maury, C. Peter J"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    1-Palmitoyl-2-(9′-oxononanoyl)-sn-glycero-3-phosphocholine, an Oxidized Phospholipid, Accelerates Finnish Type Familial Gelsolin Amyloidosis in Vitro by Mahalka, Ajay K, Maury, C. Peter J, Kinnunen, Paavo K. J

    Published in Biochemistry (Easton) (07-06-2011)
    “…Finnish type familial amyloidosis (FAF) is a neurodegenerative disease, which involves the deposition of D187N or -Y mutant gelsolin fragments as amyloid in…”
    Get full text
    Journal Article
  2. 2

    Treatment strategies for amyloid A amyloidosis by Pettersson, T, Konttinen, Y T, Maury, C P J

    Published in Expert opinion on pharmacotherapy (01-08-2008)
    “…Amyloid A (AA) amyloidosis is a serious complication of a wide range of chronic inflammatory, infectious and neoplastic diseases. A longstanding overproduction…”
    Get more information
    Journal Article
  3. 3

    Raised circulating interleukin-18 levels in reactive AA-amyloidosis by Maury, C. P. J., Tiitinen, S., Laiho, K., Kaarela, K., Liljeström, M.

    Published in Amyloid (01-06-2002)
    “…Objective. to study the circulating levels of interleukin-18 (IL-18), a proinflammatory cytokine implicated in the T helper 1 response, inpatients with…”
    Get full text
    Journal Article
  4. 4

    Correlation Of Persistently High Serum Amyloid A Protein And C-Reactive Protein Concentrations With Rapid Progression Of Secondary Amyloidosis by Falck, Hans M., Maury, C. Peter J., Teppo, Anna-Maija, Wegelius, Otto

    “…The importance of serum amyloid A protein in the progression of renal failure was studied over three years in 28 patients with secondary (amyloid A type)…”
    Get full text
    Journal Article
  5. 5

    Reduced amyloid-A-degrading activity in serum in amyloidosis associated with rheumatoid arthritis by Wegelius, O, Teppo, A M, Maury, C P

    “…The ability to degrade amyloid A fibrils was studied in the serum of 31 patients with amyloidosis associated with rheumatoid arthritis, 33 patients with…”
    Get full text
    Journal Article
  6. 6

    Urinary sialic acid levels in aspartylglycosaminuria by Maury, C P

    Published in Clinica chimica acta (22-01-1981)
    “…Urinary sialoglycoconjugates were studied in 22 patients with inherited deficiency of 1-aspartamido-beta-N-acetylglucosamine amidohydrolase…”
    Get more information
    Journal Article
  7. 7

    No evidence of amyloidosis in type I diabetics treated with continuous subcutaneous insulin infusion by Koivisto, V A, Teppo, A M, Maury, C P, Taskinen, M R

    Published in Diabetes (New York, N.Y.) (01-01-1983)
    “…A recent study has demonstrated secondary amyloidosis in dogs treated with continuous intravenous insulin infusion. Since elevated levels of serum amyloid A…”
    Get full text
    Journal Article
  8. 8

    Urinary excretion of sialic acid-containing saccharides in systemic lupus erythematosus by Maury, C P, Sjöblom, C, Wegelius, O

    Published in Arthritis and rheumatism (01-09-1981)
    “…Urinary sialic acid-containing trisaccharides, total sialic acid, and serum sialic acid were studied in 17 patients with systemic lupus erythematosus (SLE) and…”
    Get more information
    Journal Article
  9. 9

    Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome by Maury, C P, Räsänen, V, Teppo, A M, Helve, T, Wegelius, O

    Published in Arthritis and rheumatism (01-09-1982)
    “…Group I pepsinogens were measured by radioimmunoassay in the sera of 93 patients with rheumatic diseases and 99 controls. Patients with rheumatoid arthritis…”
    Get more information
    Journal Article